Max Healthcare Institute Limited (BOM:543220)
India · Delayed Price · Currency is INR 1,098.55
-27.95 (-2.48%)
At close: Jul 31, 2026
Max Healthcare Institute Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 83,735 | 83,735 | 70,285 | 54,060 | 45,626 | 39,366 |
Revenue Growth | 19.14% | 19.14% | 30.01% | 18.49% | 15.90% | 56.96% |
Gross Profit Gross Profit Growth | 52,263 | 52,263 | 43,774 | 33,531 | 28,312 | 21,885 |
Operating Income Operating Income Growth | 17,990 | 17,990 | 15,275 | 12,753 | 10,240 | 7,580 |
Net Income Net Income Growth | 14,424 | 14,424 | 10,759 | 10,576 | 11,035 | 6,051 |
Earnings Per Share EPS Growth | 14.76 | 14.76 | 11.01 | 10.84 | 11.36 | 6.24 |
EPS Growth | 34.06% | 34.06% | 1.57% | -4.58% | 82.05% | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 6,658 | 6,658 | 6,616 | 9,798 | 13,743 | 4,810 |
Total Debt Total Debt Growth | 34,784 | 34,784 | 30,103 | 12,990 | 6,890 | 9,134 |
Net Cash (Debt) Net Cash Growth | -28,126 | -28,126 | -23,487 | -3,191 | 6,854 | -4,324 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -28.78 | -28.78 | -24.03 | -3.27 | 7.05 | -4.46 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 16,333 | 16,333 | 14,380 | 11,217 | 12,841 | 7,405 |
Capital Expenditures CapEx Growth | -14,845 | -14,845 | -9,445 | -7,860 | -3,356 | -5,533 |
Free Cash Flow Free Cash Flow Growth | 1,488 | 1,488 | 4,935 | 3,357 | 9,485 | 1,872 |
Free Cash Flow Growth | -69.85% | -69.85% | 46.99% | -64.61% | 406.74% | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 62.41% | 62.41% | 62.28% | 62.02% | 62.05% | 55.59% |
Operating Margin | 21.48% | 21.48% | 21.73% | 23.59% | 22.44% | 19.25% |
Pretax Margin | 20.01% | 20.01% | 20.01% | 25.26% | 23.31% | 18.77% |
Profit Margin | 17.23% | 17.23% | 15.31% | 19.56% | 24.19% | 15.37% |
FCF Margin | 1.78% | 1.78% | 7.02% | 6.21% | 20.79% | 4.75% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 1.500 | 1.500 | 1.000 |
Dividend Per Share Growth | 33.33% | 33.33% | 0% | 50.00% | - |
Dividend Yield | 0.18% | 0.21% | 0.14% | 0.18% | 0.23% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 74.43 | 64.88 | 99.10 | 75.39 | 38.80 | 55.59 |
Forward PE | 56.09 | 50.33 | 60.58 | 53.35 | 36.97 | 36.67 |
P/FCF Ratio | 718.59 | 628.95 | 216.05 | 237.51 | 45.14 | 179.70 |
PS Ratio | 12.77 | 11.18 | 15.17 | 14.75 | 9.38 | 8.55 |